Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
Facteur d'impact: 2.9 Facteur d'impact sur 5 ans: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimer: 0743-4863
ISSN En ligne: 2162-660X

Volumes:
Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20
pages 27-105

Optimizing Drug Delivery Systems Using Systematic "Design of Experiments." Part I: Fundamental Aspects

Bhupinder Singh
University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Studies, Panjab University, Chandigarh, India 160014; UGC Centre of Excellence in Applications of Nanomaterials, Nanoparticles and Nanocomposites (Biomedical Sciences), Panjab University, Chandigarh, India 160014
Rajiv Kumar
Pharmaceutics Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
Naveen Ahuja
Pharmaceutics Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India

RÉSUMÉ

Design of an impeccable drug delivery product normally encompasses multiple objectives. For decades, this task has been attempted through trial and error, supplemented with the previous experience, knowledge, and wisdom of the formulator. Optimization of a pharmaceutical formulation or process using this traditional approach involves changing one variable at a time. Using this methodology, the solution of a specific problematic formulation characteristic can certainly be achieved, but attainment of the true optimal composition is never guaranteed. And for improvement in one characteristic, one has to trade off for degeneration in another. This customary approach of developing a drug product or process has been proved to be not only uneconomical in terms of time, money, and effort, but also unfavorable to fix errors, unpredictable, and at times even unsuccessful.
On the other hand, the modern formulation optimization approaches, employing systematic Design of Experiments (DoE), are extensively practiced in the development of diverse kinds of drug delivery devices to improve such irregularities. Such systematic approaches are far more advantageous, because they require fewer experiments to achieve an optimum formulation, make problem tracing and rectification quite easier, reveal drug/polymer interactions, simulate the product performance, and comprehend the process to assist in better formulation development and subsequent scale-up. Optimization techniques using DoE represent effective and cost-effective analytical tools to yield the "best solution" to a particular "problem." Through quantification of drug delivery systems, these approaches provide a depth of understanding as well as an ability to explore and defend ranges for formulation factors, where experimentation is completed before optimization is attempted. The key elements of a DoE optimization methodology encompass planning the study objectives, screening of influential variables, experimental designs, postulation of mathematical models for various chosen response characteristics, fitting experimental data into these model(s), mapping and generating graphic outcomes, and design validation using model-based response surface methodology.
The broad topic of DoE optimization methodology is covered in two parts. Part I of the review attempts to provide thought-through and thorough information on diverse DoE aspects organized in a seven-step sequence. Besides dealing with basic DoE terminology for the novice, the article covers the niceties of several important experimental designs, mathematical models, and optimum search techniques using numeric and graphical methods, with special emphasis on computer-based approaches, artificial neural networks, and judicious selection of designs and models.


Articles with similar content:

Insulin Self-Association and the Relationship to Pharmacokinetics and Pharmacodynamics
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.18, 2001, issue 2
Ronald E. Chance, Bruce H. Frank, Michael R. DeFelippis
A Mathematical Framework for Minimally Invasive Tumor Ablation Therapies
Critical Reviews™ in Biomedical Engineering, Vol.42, 2014, issue 5
Sheldon K. Hall, Ean Hin Ooi , Stephen J. Payne
Obstructive Sleep Apnea: Part II. Surgical Approaches to Sleep Apnea
Journal of Long-Term Effects of Medical Implants, Vol.14, 2004, issue 3
Thomas J. Gampper, Martin Hoard, Jeremy A. Benedetti
Abstract of "Drug-Eluting Stents: Some Lessons for the Ethics of Medical Nanotechnology"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
George J. Agich
MODELING HEAT CONDUCTION FROM FIRST PRINCIPLES
Annual Review of Heat Transfer, Vol.17, 2014, issue N/A
Keivan Esfarjani, Jivtesh Garg, Gang Chen